{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:13:04Z","timestamp":1780920784258,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2021\/004251"],"award-info":[{"award-number":["CRG\/2021\/004251"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/CPHE\/15\/1\/502050"],"award-info":[{"award-number":["IA\/CPHE\/15\/1\/502050"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007338","name":"All India Institute of Medical Sciences New Delhi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.tranon.2025.102403","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T15:03:03Z","timestamp":1745679783000},"page":"102403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Aberrant overexpression of m6A writer and reader genes in pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL)"],"prefix":"10.1016","volume":"56","author":[{"given":"Sumedha","family":"Saluja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7296-6088","authenticated-orcid":false,"given":"Shuvadeep","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3110-9239","authenticated-orcid":false,"given":"Gunjan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpi","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7155-2257","authenticated-orcid":false,"given":"Karthikeyan","family":"Pethusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0108-2920","authenticated-orcid":false,"given":"Parthaprasad","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-8702","authenticated-orcid":false,"given":"Anita","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhradip","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Bakhshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanth Kumar","family":"Palanichamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tranon.2025.102403_bib0001","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00018-017-2620-z","article-title":"Molecular processes involved in B cell acute lymphoblastic leukaemia","volume":"75","author":"Malouf","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"15","key":"10.1016\/j.tranon.2025.102403_bib0002","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s00018-012-1186-z","article-title":"Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?","volume":"70","author":"Bell","year":"2013","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.tranon.2025.102403_bib0003","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2407-10-59","article-title":"Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival","volume":"10","author":"Schaeffer","year":"2010","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2025.102403_bib0004","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bcmd.2011.02.005","article-title":"Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities","volume":"46","author":"Stoskus","year":"2011","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"10.1016\/j.tranon.2025.102403_bib0005","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1172\/JCI80046","article-title":"RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation","volume":"126","author":"Palanichamy","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tranon.2025.102403_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.588101","article-title":"Diagnostic Utility of IGF2BP1 and Its Targets as Potential Biomarkers in ETV6-RUNX1 Positive B-Cell Acute Lymphoblastic Leukemia","volume":"11","author":"Sharma","year":"2021","journal-title":"Front Oncol"},{"issue":"7397","key":"10.1016\/j.tranon.2025.102403_bib0007","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.tranon.2025.102403_bib0008","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1101\/gad.262766.115","article-title":"RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation","volume":"29","author":"Yue","year":"2015","journal-title":"Genes Dev"},{"issue":"9","key":"10.1016\/j.tranon.2025.102403_bib0009","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/febs.13614","article-title":"N 6-methyladenosine modification in mRNA : machinery, function and implications for health and diseases","volume":"283","author":"Maity","year":"2016","journal-title":"FEBS J"},{"issue":"3","key":"10.1016\/j.tranon.2025.102403_bib0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.tranon.2025.102403_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13027-021-00411-1","article-title":"The m6A methyltransferase METTL3 affects autophagy and progression of nasopharyngeal carcinoma by regulating the stability of lncRNA ZFAS1","volume":"17","author":"Peng","year":"2022","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.tranon.2025.102403_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173134","article-title":"METTL3 regulates the malignancy of cervical cancer via post-transcriptional regulation of RAB2B","volume":"879","author":"Hu","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.tranon.2025.102403_bib0013","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hep.28885","article-title":"METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N 6-methyladenosine-dependent primary MicroRNA processing","volume":"65","author":"Ma","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.tranon.2025.102403_bib0014","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13063-022-06033-1","article-title":"Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India","volume":"23","author":"Das","year":"2022","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.tranon.2025.102403_bib0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2141.2000.01891.x","article-title":"The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the Medical Research Council UKALLR1 study: The Medical Research Council UKALLR1 Study","volume":"108","author":"Lawson","year":"2000","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.tranon.2025.102403_bib0016","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3\u2032 UTRs and near Stop Codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.tranon.2025.102403_bib0017","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute Lymphoblastic Leukemia","volume":"339","author":"Pui","year":"1998","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.tranon.2025.102403_bib0018","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3324\/haematol.2012.080432","article-title":"Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts","volume":"98","author":"Chiaretti","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.tranon.2025.102403_bib0019","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2008-01-130237","article-title":"What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children\u2019s Cancer Group and Cancer and Leukemia Group B studies","volume":"112","author":"Stock","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.tranon.2025.102403_bib0020","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/leu.2008.251","article-title":"Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"22","author":"Nguyen","year":"2008","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.tranon.2025.102403_bib0021","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1172\/JCI61203","article-title":"Molecular genetics of B-precursor acute lymphoblastic leukemia","volume":"122","author":"Mullighan","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tranon.2025.102403_bib0022","unstructured":"Horton TM, Park JR, Newburger P, Rosmarin AG. Prognostic factors and risk group stratification for acute lymphoblastic leukemia\/lymphoblastic lymphoma in children and adolescents. In: UpToDate, Connor RF (Ed), Wolters Kluwer."},{"issue":"11","key":"10.1016\/j.tranon.2025.102403_bib0023","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.tranon.2025.102403_bib0024","article-title":"Molecular markers in ALL: Clinical implications","volume":"33","author":"Kimura","year":"2020","journal-title":"Best Pr Res Clin Haematol"},{"issue":"9","key":"10.1016\/j.tranon.2025.102403_bib0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1470-2045(08)70229-8","article-title":"Bone-marrow relapse in paediatric acute lymphoblastic leukaemia","volume":"9","author":"Bailey","year":"2008","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.tranon.2025.102403_bib0026","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood-2006-02-002824","article-title":"Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"108","author":"Bhojwani","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.tranon.2025.102403_bib0027","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2007-01-067785","article-title":"Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone","volume":"110","author":"Choi","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.tranon.2025.102403_bib0028","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1586\/17474086.2015.978281","article-title":"Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention","volume":"8","author":"Ceppi","year":"2015","journal-title":"Expert Rev Hematol"},{"issue":"10","key":"10.1016\/j.tranon.2025.102403_bib0029","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4161\/cc.7.10.5885","article-title":"Mechanism of relapse in pediatric acute lymphoblastic leukemia","volume":"7","author":"Henderson","year":"2008","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.tranon.2025.102403_bib0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","article-title":"The m 6 A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells","volume":"62","author":"Lin","year":"2016","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.tranon.2025.102403_bib0031","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.tranon.2025.102403_bib0032","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.tranon.2025.102403_bib0033","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1158\/2643-3230.BCD-22-0156","article-title":"METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL","volume":"4","author":"Wu","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"2","key":"10.1016\/j.tranon.2025.102403_bib0034","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 Inhibits Hematopoietic Stem\/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.tranon.2025.102403_bib0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12943-020-01249-8","article-title":"Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer","volume":"19","author":"Wang","year":"2020","journal-title":"Mol Cancer"},{"issue":"31","key":"10.1016\/j.tranon.2025.102403_bib0036","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1038\/s41388-020-1338-9","article-title":"LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression","volume":"39","author":"Sun","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.tranon.2025.102403_bib0037","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N 6 -Methyladenosine RNA Demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.tranon.2025.102403_bib0038","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-20-0132","article-title":"FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155\/23a Cluster-MXI1 Feedback Circuit in Glioma","volume":"80","author":"Xiao","year":"2020","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.tranon.2025.102403_bib0039","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/mc.22782","article-title":"FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting \u03b2-catenin through mRNA demethylation","volume":"57","author":"Zhou","year":"2018","journal-title":"Mol Carcinog"},{"issue":"4","key":"10.1016\/j.tranon.2025.102403_bib0040","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3892\/or.2017.5904","article-title":"FTO expression is associated with the occurrence of gastric cancer and prognosis","volume":"38","author":"Xu","year":"2017","journal-title":"Oncol Rep"},{"issue":"6","key":"10.1016\/j.tranon.2025.102403_bib0041","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s10620-018-5452-2","article-title":"Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer","volume":"64","author":"Li","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.tranon.2025.102403_bib0042","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3389\/fonc.2020.00769","article-title":"Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"issue":"20","key":"10.1016\/j.tranon.2025.102403_bib0043","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41388-022-02306-w","article-title":"RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m6A-YTHDF2-dependent manner","volume":"41","author":"Tan","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.tranon.2025.102403_bib0044","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13578-022-00798-3","article-title":"m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer","volume":"12","author":"Duan","year":"2022","journal-title":"Cell Biosci"},{"issue":"1","key":"10.1016\/j.tranon.2025.102403_bib0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s12935-021-02090-9","article-title":"The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma","volume":"21","author":"Yu","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"40","key":"10.1016\/j.tranon.2025.102403_bib0046","doi-asserted-by":"crossref","first-page":"64527","DOI":"10.18632\/oncotarget.11743","article-title":"Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.tranon.2025.102403_bib0047","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.stem.2020.04.001","article-title":"Leukemogenic Chromatin Alterations Promote AML Leukemia Stem Cells via a KDM4C-ALKBH5-AXL Signaling Axis","volume":"27","author":"Wang","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.tranon.2025.102403_bib0048","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.stem.2020.04.009","article-title":"RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia","volume":"27","author":"Shen","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tranon.2025.102403_bib0049","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.leukres.2016.05.009","article-title":"Defining the significance of IGF2BP1 overexpression in t(12;21)(p13;q22)-positive leukemia REH cells","volume":"47","author":"Stoskus","year":"2016","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.tranon.2025.102403_bib0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","article-title":"The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability","volume":"54","author":"Zhang","year":"2022","journal-title":"Exp Mol Med"},{"issue":"10","key":"10.1016\/j.tranon.2025.102403_bib0051","doi-asserted-by":"crossref","first-page":"eaar8263","DOI":"10.1126\/sciadv.aar8263","article-title":"Cross-talk among writers, readers, and erasers of m 6 A regulates cancer growth and progression","volume":"4","author":"Panneerdoss","year":"2018","journal-title":"Sci Adv"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:28:59Z","timestamp":1762597739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325001342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":51,"alternative-id":["S1936523325001342"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102403","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant overexpression of m6A writer and reader genes in pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL)","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}],"article-number":"102403"}}